Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "Sorafenib"

ADD TO MY LIST
 
Acalculous Cholecystitis in a Patient with Hepatocellular Carcinoma on Sorafenib

Author(s): Mariko Sanda | Hideyuki Tamai | Hisanobu Deguchi | Yoshiyuki Mori | Kosaku Moribata | Naoki Shingaki | Kazuki Ueda | Izumi Inoue | Takao Maekita | Mikitaka Iguchi | Kimihiko Yanaoka | Masashi Oka | Masao Ichinose
Metastatic renal cell cancer treatments: An indirect comparison meta-analysis

Author(s): Mills Edward | Rachlis Beth | O'Regan Chris | Thabane Lehana | Perri Dan
Sorafenib in Hepatocellular Carcinoma

Author(s): Emilio Bajetta | Giuseppe Procopio | Andrea Colombo | Valentina Guadalupi | Elena Verzoni | Filippo Pietrantonio | Sara Pusceddu | Mariangela Manzoni | Arpine Gevorgyan | Roberto Buzzoni
Neoadjuvant sorafenib combined with gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma

Author(s): Nicolas Williet | Olivier Dubreuil | Tarek Boussaha | Isabelle Trouilloud | Bruno Landi | Martin Housset | Muriel Botti | Philippe Rougier | Jacques Belghiti | Julien Taieb
Liver Resection after Downstaging Hepatocellular Carcinoma with Sorafenib

Author(s): L. Barbier | F. Muscari | S. Le Guellec | A. Pariente | P. Otal | B. Suc
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Author(s): Yuan RuiRong | Kay Andrea | Berg William | Lebwohl David
Identifying differentially regulated subnetworks from phosphoproteomic data

Author(s): Klammer Martin | Godl Klaus | Tebbe Andreas | Schaab Christoph
Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options

Author(s): Francesco Perri, Giuseppe Di Lorenzo, Giuseppina Della Vittoria Scarpati, Carlo Buonerba
Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease

Author(s): Stec Rafał | Grala Bartłomiej | Mączewski Michał | Bodnar Lubomir | Szczylik Cezary
Successful treatment of a brain-metastasized renal cell carcinoma

Author(s): Walid, M. Sami | Johnston, Kim W.
Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma

Author(s): Yeo Winnie | Chen Pei-Jer | Furuse Junji | Han Kwang-Hyub | Hsu Chiun | Lim Ho-Yeong | Moon Hanlim | Qin Shukui | Yeoh Ee-Min | Ye Sheng-Long
Anti-angiogenesis therapies: their potential in cancer management

Author(s): Andrew Eichholz | Shairoz Merchant | Andrew M Gaya
Sorafenib in metastatic MTC – a case report and minireview of the literature

Author(s): Mila Petrova | Zhasmina Mihaylova | Albena Fakirova
Everolimus – a new approach in the treatment of renal cell carcinoma

Author(s): G Anandappa | AE Hollingdale | TG Eisen
Targeted therapy in melanoma

Author(s): Hussein Tawbi | Neelima Nimmagadda
Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib

Author(s): Christoph Roderburg, Jhenee Bubenzer, Michael Spannbauer, Nicole do O, Andreas Mahnken, Tom Ludde, Christian Trautwein, Jens J Tischendorf
Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient

Author(s): Sang Ock Kim, Sang Young Han, Yang Hyun Baek, Sung Wook Lee, Ji Sun Han, Byung Geun Kim, Jin Han Cho, Kyung Jin Nam
Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report

Author(s): Yubao Wang, Kermit V Speeg, William Kenneth Washburn, Glenn Halff
Sustained treatment response of metastatic hepatocellular carcinoma with bevacizumab and sorafenib

Author(s): Christina Wich, Abbas Agaimy, Deike Strobel, Thaddäus Till Wissniowski, Arndt Hartmann, Matthias Ocker
Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives

Author(s): Michael Höpfner, Detlef Schuppan, Hans Scherübl
Evolution of systemic therapy of advanced hepatocellular carcinoma

Author(s): Thomas Yau, Pierre Chan, Richard Epstein, Ronnie T Poon
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines

Author(s): Eustace Alex | Crown John | Clynes Martin | O'Donovan Norma
Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

Author(s): Hoffmann K | Glimm H | Radeleff B | Richter G | Heining C | Schenkel I | Zahlten-Hinguranage A | Schirrmacher P | Schmidt J | Büchler MW | Jaeger D | von Kalle C | Schemmer P
Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion

Author(s): Cheepala Satish | Yin Weihong | Syed Zanobia | Gill Jennifer | McMillian Alaina | Kleiner Heather | Lynch Mark | Loganantharaj Rasiah | Trutschl Marjan | Cvek Urska | Clifford John
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib

Author(s): Horger Marius | Lauer Ulrich | Schraml Christina | Berg Christoph | Koppenhöfer Ursula | Claussen Claus | Gregor Michael | Bitzer Michael
Prevention of pulmonary vascular and myocardial remodeling by the combined tyrosine and serine-/threonine kinase inhibitor, sorafenib, in pulmonary hypertension and right heart failure

Author(s): M. Klein | R. T. Schermuly | P. Ellinghaus | H. Milting | B. Riedl | H. A. Ghofrani | F. Grimminger | S. Schäfer
Optimized management of advanced hepatocellular carcinoma: Four long-lasting responses to sorafenib

Author(s): Giovanni Abbadessa | Lorenza Rimassa | Tiziana Pressiani | Cynthia Carrillo-Infante | Emanuele Cucchi | Armando Santoro
Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study

Author(s): Zhang Hailiang | Dong Baijun | Lu Jiade | Yao Xudong | Zhang Shilin | Dai Bo | Shen Yijun | Zhu Yao | Ye Dingwei | Huang Yiran
Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations

Author(s): Preto Ana | Gonçalves Joana | Rebocho Ana | Figueiredo Joana | Meireles Ana | Rocha Ana | Vasconcelos Helena | Seca Hugo | Seruca Raquel | Soares Paula | Sobrinho-Simões Manuel
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways

Author(s): Pignochino Ymera | Grignani Giovanni | Cavalloni Giuliana | Motta Manuela | Tapparo Marta | Bruno Stefania | Bottos Alessia | Gammaitoni Loretta | Migliardi Giorgia | Camussi Giovanni | Alberghini Marco | Torchio Bruno | Ferrari Stefano | Bussolino Federico | Fagioli Franca | Picci Piero | Aglietta Massimo
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA

Author(s): Alessandro Granito | Luigi Bolondi
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Author(s): Greten Tim | Forner Alejandro | Korangy Firouzeh | N'Kontchou Gisele | Barget Nathalie | Ayuso Carmen | Ormandy Lars | Manns Michael | Beaugrand Michel | Bruix Jordi
Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

Author(s): Haubeiss Silke | Schmid Jens | Mürdter Thomas | Sonnenberg Maike | Friedel Godehard | van der Kuip Heiko | Aulitzky Walter
Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenib

Author(s): Jain Lokesh | Sissung Tristan | Danesi Romano | Kohn Elise | Dahut William | Kummar Shivaani | Venzon David | Liewehr David | English Bevin | Baum Caitlin | Yarchoan Robert | Giaccone Giuseppe | Venitz Jürgen | Price Douglas | Figg William
The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells

Author(s): Schult Catrin | Dahlhaus Meike | Ruck Sabine | Sawitzky Mandy | Amoroso Francesca | Lange Sandra | Etro Daniela | Glass Aenne | Fuellen Georg | Boldt Sonja | Wolkenhauer Olaf | Neri Luca | Freund Mathias | Junghanss Christian
TUMOR ANGIOGENESIS–IMPLICATIONS IN CANCER THERAPY

Author(s): L. Miron | B. Gafton | M. Marinca
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling

Author(s): Wessen Maruwge | Pádraig D’Arcy | Annika Folin | Slavica Brnjic | Johan Wejde | et al
Multiple roles and therapeutic implications of Akt signaling in cancer

Author(s): Emiliano Calvo | Victoria Bolós | Enrique Grande
Role of everolimus in the treatment of renal cell carcinoma

Author(s): Saby George | Ronald M Bukowski
Role of cetuximab and sorafenib in treatment of metastatic colorectal cancer

Author(s): Galal K | Khaled Z | Mourad Abdel Monem
Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial

Author(s): Combs Stephanie | Habermehl Daniel | Ganten Tom | Schmidt Jan | Edler Lutz | Burkholder Iris | Jäkel Oliver | Haberer Thomas | Debus Jürgen
Complete response for advanced liver cancer during sorafenib therapy: Case Report

Author(s): Sacco Rodolfo | Bargellini Irene | Gianluigi Giannelli | Bertini Marco | Bozzi Elena | Altomare Emanuele | Battaglia Valentina | Romano Antonio | Bertoni Michele | Capria Alfonso | Bresci Giampaolo | Bartolozzi Carlo
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

Author(s): Pignochino Ymera | Sarotto Ivana | Peraldo-Neia Caterina | Penachioni Junia | Cavalloni Giuliana | Migliardi Giorgia | Casorzo Laura | Chiorino Giovanna | Risio Mauro | Bardelli Alberto | Aglietta Massimo | Leone Francesco
Current approach in the treatment of hepatocellular carcinoma

Author(s): Luigi Rossi | Federica Zoratto | Anselmo Papa | Francesca Iodice | Marina Minozzi | Luigi Frati | Silverio Tomao
Arterial-phase contrast-enhanced ultrasonography for evaluating anti-angiogenesis treatment: A pilot study

Author(s): Keiko Yoshida, Tomihiko Hirokawa, Fuminori Moriyasu, Longzhong Liu, Guang-Jian Liu, Masahiko Yamada, Yasuharu Imai
Randomize Trial of Cisplatin plus Gemcitabine with either Sorafenib or Placebo as First-line Therapy for Non-small Cell Lung Cancer

Author(s): Yan WANG | Lin WANG | Yutao LIU | Shufei YU | Xiangru ZHANG | Yuankai SHI | Yan SUN
TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies

Author(s): Bruno Christian Koehler, Toni Urbanik, Binje Vick, Regina Johanna Boger, Steffen Heeger, Peter R Galle, Marcus Schuchmann, Henning Schulze-Bergkamen
Is human hepatocellular carcinoma a hormone-responsive tumor?

Author(s): Massimo Di Maio, Bruno Daniele, Sandro Pignata, Ciro Gallo, Ermelinda De Maio, Alessandro Morabito, Maria Carmela Piccirillo, Francesco Perrone
Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy

Author(s): Porta Camillo | Paglino Chiara | Imarisio Ilaria | Canipari Cinzia | Chen Kristina | Neary Maureen | Duh Mei
Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma

Author(s): Zustovich F | Lombardi G | Pastorelli D | Farina P | Dal Bianco M | De Zorzi L | Dalla Palma M | Nicoletto O | Zagonel V
Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanoma

Author(s): Mangiameli David | Blansfield Joseph | Kachala Stephan | Lorang Dominique | Schafer Peter | Muller George | Stirling David | Libutti Steven
Treatment Approaches for Hepatocellular Carcinoma

Author(s): Khaldoun Almhanna | Richard Kim | Sujith Kalmadi
Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature

Author(s): Anneleen Van Hootegem | Chris Verslype | Werner Van Steenbergen
Współistnienie zespołu ręka–stopa i rozległych zmian rumieniowo- -obrzękowych – skórne działania niepożądane po sorafenibie

Author(s): Alina Jankowska-Konsur | Agnieszka Rusin-Tupikowska | Krzysztof Tupikowski | Joanna Maj
New Sorafenib Derivatives: Synthesis, Antiproliferative Activity Against Tumour Cell Lines and Antimetabolic Evaluation

Author(s): Željka Babić | Maja Crkvenčić | Zrinka Rajić | Ana-Matea Mikecin | Marijeta Kralj | Jan Balzarini | Mariya Petrova | Jos Vanderleyden | Branka Zorc
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan

Author(s): Hiroki Nishikawa | Yukio Osaki | Ryuichi Kita | Toru Kimura
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma with Sorafenib in a Reference Center in Mexico

Author(s): Axel Costilla-Montero | Benjamín Guadarrama-Benítez | Marco A. Aragón-Castro | Omar Morales-Ordaz | Rubén Gutiérrez-Rosales | Claudia Carrillo-Ponce | Marcela Janka-Zires | Luis Gabriel Vázquez-Lavista
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report

Author(s): Scheele Jürgen | Harder Jan | Stankovic Zoran | Räpple Daniel | Dorn Annette | Spangenberg Hans | Blum Hubert
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview

Author(s): Marra Monica | Sordelli Ignazio | Lombardi Angela | Lamberti Monica | Tarantino Luciano | Giudice Aldo | Stiuso Paola | Abbruzzese Alberto | Sperlongano Rossella | Accardo Marina | Agresti Massimo | Caraglia Michele | Sperlongano Pasquale
Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3

Author(s): Fang-Ming Gu | Quan-Lin Li | Qiang Gao | Jia-Hao Jiang | Xiao-Yong Huang | Jin-Feng Pan | Jia Fan | Jian Zhou
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma

Author(s): Busch Jonas | Seidel Christoph | Weikert Steffen | Wolff Ingmar | Kempkensteffen Carsten | Weinkauf Lisa | Hinz Stefan | Magheli Ahmed | Miller Kurt | Grünwald Viktor
Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib

Author(s): Roulin Didier | Waselle Laurent | Dormond-Meuwly Anne | Dufour Marc | Demartines Nicolas | Dormond Olivier
Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma

Author(s): Muhammad W. Saif | Iris Isufi | Jennifer Peccerillo | Kostas N. Syrigos
Immunological Effects of Multikinase Inhibitors for Kidney Cancer: A Clue for Integration with Cellular Therapies?

Author(s): Camillo Porta, Chiara Paglino, Ilaria Imarisio, Carlo Ganini, Paolo Pedrazzoli
Synthesis and Cytotoxic Evaluation of Novel N-Methyl-4-phenoxypicolinamide Derivatives

Author(s): Wei Li | Xin Zhai | Lu Ding | Limin Sun | Xiaomei Chen | Ping Gong | Tiemin Sun
Save time & money - Smart Internet Solutions      Why do you need a reservation system?